Follow
Esther Bernaldo de Quirós
Esther Bernaldo de Quirós
Investigadora Postdoctoral, Instituto de Investigación Sanitaria Gregorio Marañón (IISGM)
Verified email at iisgm.com
Title
Cited by
Cited by
Year
Imbalance in T-helper 17 cells and targeted therapy in an infant with SAM-like syndrome
A Hernández-Martín, R Kennedy-Batalla, E Cañedo, ...
New England Journal of Medicine 381 (22), 2176-2178, 2019
272019
Basiliximab impairs regulatory T cell (TREG) function and could affect the short-term graft acceptance in children with heart transplantation
J López-Abente, M Martínez-Bonet, E Bernaldo-de-Quirós, M Camino, ...
Scientific reports 11 (1), 1-12, 2021
212021
Immune dysregulation and Th2 polarization are associated with atopic dermatitis in heart‐transplant children: A delicate balance between risk of rejection or atopic symptoms
J López‐Abente, E Bernaldo‐de‐Quirós, M Camino, N Gil, E Panadero, ...
American Journal of Transplantation 19 (5), 1536-1544, 2019
172019
A Novel GMP Protocol to Produce High-Quality Treg Cells From the Pediatric Thymic Tissue to Be Employed as Cellular Therapy.
E Bernaldo-de-Quirós, B Cózar, R López-Esteban, M Clemente, ...
Frontiers in immunology 13, 893576-893576, 2022
82022
Ectopic FOXP3 Expression in Combination with TGF-β1 and IL-2 Stimulation Generates Limited Suppressive Function in Human Primary Activated Thymocytes Ex Vivo
J Gallego-Valle, S Gil-Manso, A Pita, E Bernaldo-de-Quirós, ...
Biomedicines 9 (5), 461, 2021
72021
Multidimensional analysis of immune cells from COVID-19 patients identified cell subsets associated with the severity at hospital admission
S Gil-Manso, D Herrero-Quevedo, D Carbonell, M Martínez-Bonet, ...
Plos Pathogens 19 (6), e1011432, 2023
52023
The presence of a marked imbalance between regulatory T cells and effector T cells reveals that tolerance mechanisms could be compromised in heart transplant children
E Bernaldo-de-Quirós, J López-Abente, M Camino, N Gil, E Panadero, ...
Transplantation direct 7 (5), 2021
52021
A New Generation of Cell Therapies Employing Regulatory T Cells (Treg) to Induce Immune Tolerance in Pediatric Transplantation
E Bernaldo-de-Quirós, M Pion, M Martínez-Bonet, R Correa-Rocha
Frontiers in Pediatrics 10, 2022
32022
" First-In-Human" Clinical Trial Employing Adoptive Transfer of Autologous Thymus-Derived Treg Cells (thyTreg) to Prevent Graft Rejection in Heart-Transplanted Children
E Bernaldo de Quiros, M Camino, N Gil, E Panadero, C Medrano, ...
Transplantation 102, S205-S205, 2018
32018
213.2: Preliminary results of the first clinical trial to prevent graft rejection in heart transplant children employing a cellular therapy with autologous treg obtained from …
E Bernaldo-de-Quirós, M Camino, JM Gil-Jaurena, N Gil, ...
Transplantation 106 (9S), S28, 2022
12022
Thymus-derived Treg infusion to prevent graft rejection in heart-transplanted children: initial exploration of a new therapeutic arsenal to boost immune tolerance
EB de Quirós, VA Pérez, M Clemente, JM Gil-Jaurena, MT González, ...
Transplantation 101 (5S-3), S36, 2017
12017
First-in-human therapy with Treg produced from thymic tissue (thyTreg) in a heart transplant infant
E Bernaldo-de-Quirós, M Camino, M Martínez-Bonet, JM Gil-Jaurena, ...
Journal of Experimental Medicine 220 (12), e20231045, 2023
2023
AVIDIN-BASED CHIMERIC ANTIGEN RECEPTOR SPECIFICALLY ENHANCES THYMUS-DERIVED REGULATORY T CELLS ACTIVATION AND FUNCTIONALITY
J Gallego Valle, V Perez Fernandez, M Martinez-Bonet, R Lopez, ...
CYTOTHERAPY 24 (5), S128-S129, 2022
2022
A NOVEL GMP PROTOCOL USING THE HUMAN THYMUS AS A NEW SOURCE OF REGULATORY T CELLS (THYTREG) TO BE EMPLOYED AS AN AUTOLOGOUS CELLULAR THERAPY IN HEART TRANSPLANTED CHILDREN
E Bernaldo de Quiros, M Camino, J Gil-Jaurena, N Gil, ...
CYTOTHERAPY 24 (5), S38-S39, 2022
2022
Primer ensayo clínico para prevenir el rechazo en niños trasplantados de corazón mediante una terapia celular con Treg autólogas obtenidas a partir de tejido tímico (thyTreg)
E Bernaldo de Quirós Plaza
2022
Primer ensayo clínico para prevenir el rechazo en niños trasplantados de corazón mediante una terapia celular con Treg autólogas obtenidas a partir de tejido tímico (thyTreg)
EB de Quirós Plaza
Universidad Autónoma de Madrid, 2022
2022
Avidin-based universal CAR regulatory T cells (UniCAR-Tregs): a versatile approach for future immunotherapy
J Gallego-Valle, S Gil-Manso, A Pita, E Bernaldo-de-Quiros, ...
EUROPEAN JOURNAL OF IMMUNOLOGY 51, 116-116, 2021
2021
Ectopic FOXP3 Expression in Combination with TGF-β1 and IL-2 Stimulation Generates Limited Suppressive Function in Human Primary Activated Thymocytes Ex Vivo. Biomedicines 2021 …
J Gallego-Valle, S Gil-Manso, A Pita, E Bernaldo-de-Quirós, ...
s Note: MDPI stays neu-tral with regard to jurisdictional claims in …, 2021
2021
“FIRST-IN-HUMAN” CLINICAL TRIAL EMPLOYING ADOPTIVE TRANSFER OF AUTOLOGOUS THYMUS-DERIVED TREG CELLS (THYTREG) TO PREVENT GRAFT REJECTION IN HEART-TRANSPLANTED CHILDREN
E Bernaldo-de-Quiros, M Camino, JM Gil-Jaurena, E Fernández-Santos, ...
Transplantation 104 (S3), S22, 2020
2020
Papel de las células T reguladoras en la alergia a proteínas de leche de vaca no mediada por IGE en la infancia
J Pérez Moreno
Universidad Complutense de Madrid, 2019
2019
The system can't perform the operation now. Try again later.
Articles 1–20